Barinthus Biotherapeutics plc Net Profit Margin Growth & History (BRNS)
Barinthus Biotherapeutics plc's net profit margin was −408.00% for fiscal 2024.
View full Barinthus Biotherapeutics plc company overviewBarinthus Biotherapeutics plc annual net profit margin history
| Fiscal year | Period ended | Net profit margin | Change (percentage points) |
|---|---|---|---|
| 2024 | 2024-12-31 | −408.00% | +8737.51 pp |
| 2023 | 2023-12-31 | −9,145.51% | −9157.46 pp |
| 2022 | 2022-12-31 | 11.95% | +18991.43 pp |
| 2021 | 2021-12-31 | −18,979.48% | −18612.21 pp |
| 2020 | 2020-12-31 | −367.27% | — |
Barinthus Biotherapeutics plc quarterly net profit margin
| Fiscal quarter | Period ended | Net profit margin | Change (percentage points) |
|---|---|---|---|
| Q3 2024 | 2024-09-30 | −54.21% | — |
| Q2 2023 | 2023-06-30 | −7,126.35% | −7218.32 pp |
| Q1 2023 | 2023-03-31 | −3,884.62% | −3901.90 pp |
| Q4 2022 | 2022-12-31 | −328.16% | — |
| Q3 2022 | 2022-09-30 | 133.69% | +24117.90 pp |
| Q2 2022 | 2022-06-30 | 91.97% | +45597.69 pp |
| Q1 2022 | 2022-03-31 | 17.29% | +7118.68 pp |
| Q3 2021 | 2021-09-30 | −23,984.21% | −23989.07 pp |
| Q2 2021 | 2021-06-30 | −45,505.71% | −44803.56 pp |
| Q1 2021 | 2021-03-31 | −7,101.40% | −6559.41 pp |
| Q4 2020 | 2020-12-31 | −2,953.39% | — |
| Q3 2020 | 2020-09-30 | 4.86% | — |
| Q2 2020 | 2020-06-30 | −702.15% | — |
| Q1 2020 | 2020-03-31 | −541.99% | — |
Barinthus Biotherapeutics plc net profit margin trends
Between the periods ended 2020-12-31 and 2024-12-31, Barinthus Biotherapeutics plc's net profit margin decreased from −367.27% to −408.00%, a change of −40.74 percentage points. The latest reported quarter, Q3 2024, shows −54.21%.
What net profit margin means
Net profit margin measures the percentage of revenue remaining as net income after operating costs, interest, taxes, and other expenses. It shows how much bottom-line profit or loss a company generates from each dollar of revenue.
How net profit margin is calculated
TickerStat calculates net profit margin as SEC-reported net income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Barinthus Biotherapeutics plc source filings ↗